Image-guided interventions in the musculoskeletal system require accurate detection and characterization of lesions involving bone and soft tissues. Magnetic resonance imaging (MRI) has superior soft tissue contrast resolution particularly in bone and soft tissues where computed tomography and ultrasonography have significant limitations. In addition, the multiplanar imaging capabilities of MRI facilitate targeting lesions and tracking interventional devices.
View Article and Find Full Text PDFPurpose: To evaluate the use of a self-expanding tract sealant device (BioSentry™) on the rates of pneumothorax and chest tube insertion after percutaneous lung biopsy.
Materials And Methods: In this retrospective study, we compared 318 patients who received BioSentry™ during percutaneous lung biopsy (treated group) with 1956 patients who did not (control group). Patient-, lesion-, and procedure-specific variables, and pneumothorax and chest tube insertion rates were recorded.
Objectives: Real-time magnetic resonance imaging (MRI)-guided cryoablation has been investigated in open MRI systems with low magnetic fields (0.2-0.5 T).
View Article and Find Full Text PDFObjectives: The objective of this study was to report a single-center experience with magnetic resonance imaging (MRI)-guided biopsy in the musculoskeletal system using a closed-bore, cylindrical, high-magnetic-field (1.5-T) MRI unit.
Methods: From May 2010 to July 2011, 100 consecutive MRI-guided biopsy sessions were undertaken for musculoskeletal lesions in 97 patients.
Purpose: To characterize the performance of a 980-nm diode laser ablation system in an in vivo tumor model.
Materials And Methods: This study was approved by the institutional animal care and use committee. The ablation system consisted of a 15-W, 980-nm diode laser, flexible diffusing-tipped fiber optic, and 17-gauge internally cooled catheter.
Purpose: To characterize the degree of contrast enhancement within the ablation zone immediately after radiofrequency (RF) ablation of renal tumors.
Materials And Methods: Patients with renal tumors treated with percutaneous RF ablation at one institution between January 2004 and October 2007 were retrospectively reviewed. For each tumor, computed tomography (CT) density measurements were made at four phases (noncontrast, arterial phase, parenchymal phase, and excretory phase) in each of four CT examinations (before ablation, day 0, 1 month, and 6 months).